Timo Lenderink

Summary

Affiliation: Atrium Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes
    Timo Lenderink
    Department of Cardiology, Atrium Medical Centre, Heerlen, The Netherlands
    J Am Coll Cardiol 47:307-11. 2006
  2. ncbi request reprint Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS
    Timo Lenderink
    Department of Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Am Heart J 147:865-73. 2004
  3. ncbi request reprint Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes
    Timo Lenderink
    Atrium Medical Centre, Heerlen, The Netherlands
    Eur Heart J 27:1799-804. 2006
  4. doi request reprint Prediction of 30-day mortality in older patients with a first acute myocardial infarction
    Timo Lenderink
    Department of Cardiology, Atrium Medisch Centrum, Heerlen, The Netherlands
    Cardiology 115:1-9. 2010

Detail Information

Publications4

  1. ncbi request reprint Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes
    Timo Lenderink
    Department of Cardiology, Atrium Medical Centre, Heerlen, The Netherlands
    J Am Coll Cardiol 47:307-11. 2006
    ..This study sought to evaluate the predictive value of baseline placental growth factor (PlGF) for long-term cardiovascular events in acute coronary syndromes (ACS)...
  2. ncbi request reprint Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS
    Timo Lenderink
    Department of Cardiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Am Heart J 147:865-73. 2004
    ..The glycoprotein IIb/IIIa receptor antagonist abciximab reduces the risk of thrombotic complications with percutaneous coronary intervention, but also has been associated with higher bleeding rates...
  3. ncbi request reprint Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes
    Timo Lenderink
    Atrium Medical Centre, Heerlen, The Netherlands
    Eur Heart J 27:1799-804. 2006
    ..However, it remains uncertain how soon statins should be started after an acute coronary syndrome (ACS). Recently published trials suggest starting before discharge. We hypothesize that statins should be initiated without delay...
  4. doi request reprint Prediction of 30-day mortality in older patients with a first acute myocardial infarction
    Timo Lenderink
    Department of Cardiology, Atrium Medisch Centrum, Heerlen, The Netherlands
    Cardiology 115:1-9. 2010
    ..This study sought predictors of mortality in patients aged >or=75 years with a first ST-segment elevation myocardial infarction (STEMI) and evaluated the validity of the GUSTO-I and TIMI risk models...